Results 111 to 120 of about 2,540 (169)

A narrative review of PCSK9 inhibitors: from evolocumab to novel discoveries. [PDF]

Front Pharmacol
Liu HH, Li S, Li JJ.
europepmc   +1 more source

Relative Efficacy of Alirocumab, Evolocumab, Inclisiran, and Bempedoic Acid on Lipids in Patients with Cardiovascular Disease or Familial Hypercholesterolaemia. [PDF]

J Clin Med
Khattak S, Ochoa-Ferraro A, Khan N, George S, Khan SQ, Townend JN, Dawson C, Thomas MR.   +7 more
europepmc   +1 more source

Barriers and Facilitators to the Use of Novel Injectable Lipid-Lowering Therapies in Patients with Dyslipidemia or Cardiovascular Disease: A Scoping Review. [PDF]

Medicina (Kaunas)
Caggianelli G, Iorfida M, Cavaliere R, Manzoli A, D'Angelo A, Scerbo F, Marti F, Mancin S, Cangelosi G, Rocco G, Vanzi V, Karuveettil V, Zega M, Donnoli C.   +13 more
europepmc   +1 more source

Integrating pharmacovigilance signals with real-world validation: a study on neurological events associated with PCSK9 inhibitors. [PDF]

Front Med (Lausanne)
Zhu B, Shao Q, Cui J, Fu Z, Ma Y.
europepmc   +1 more source

Determinants of circulating PCSK9 levels and the efficacy of PCSK9 inhibitor therapies in chronic kidney disease: a systematic review. [PDF]

Eur J Clin Pharmacol
Ábel T, Benczúr B, Csajbókné ÉC.
europepmc   +1 more source

Fair pricing, fair access; a systematic review of cost-effectiveness of new hyperlipidemia injectable medication in developing countries. [PDF]

Cost Eff Resour Alloc
Azari S, Pourasghari H, Rezaei MA, Behzadifar M, Salehbeigi S, Rajaei S, Jafarzadeh D, Soleimanpour S, Tajdini M.   +8 more
europepmc   +1 more source

Evinacumab Improved the Homozygous Familial Hypercholesterolemia Lipid Metabolism: A Case Report. [PDF]

J Atheroscler Thromb
Matsuda T, Osaki Y, Matsumoto N, Nakajima R, Murayama Y, Sugano Y, Iwasaki H, Mathis BJ, Sekiya M, Shimano H.   +9 more
europepmc   +1 more source

Novel Therapies, Residual Risk, Familial Hypercholesterolemia, and Digital Tools: Multispecialty Insights from a Dyslipidemia Management Survey. [PDF]

J Clin Med
Mesquita-Lousada A, Rocha-Melo-Sousa A, Teixeira C, Guimarães TR, Marques-Vieira M, Andrade JP, Ribeiro H, Neiva-Sousa M, Rocha-Neves J.   +8 more
europepmc   +1 more source

A computational model-powered platform to inform the development of GalNAc-conjugated siRNA therapeutics. [PDF]

Mol Ther Nucleic Acids
Fan X, Xiao Y, Cao K, Zhang R, Yan X.
europepmc   +1 more source